Methicillin-resistant Staphylococcus aureus (MRSA) is a type of bacteria that is resistant to certain antibiotics. These antibiotics include methicillin and other more common antibiotics such as oxacillin, penicillin and amoxicillin. Staph infections, including MRSA, occur most frequently among persons in hospitals and healthcare facilities (such as nursing homes and dialysis centers) who have weakened immune systems.
MRSA infections that occur in otherwise healthy people who have not been recently (within the past year) hospitalized or had a medical procedure (such as dialysis, surgery, catheters) are known as community-associated (CA)-MRSA infections. These infections are usually skin infections, such as abscesses, boils, and other pus-filled lesions.
Scientists say they believe as many as 53 million people may carry the superbug MRSA.
Thousands of patients in hospitals each year are at risk of potentially fatal infections because health care workers do not wash their hands on enough occasions.
A new antibiotic with the ability to fight drug-resistant superbugs has been developed by researchers at drug company Merck's research laboratories in New Jersey.
Cosmetic considerations and a perceived lack of patent opportunities could be stopping the pharmaceutical and healthcare industries from investing in the development of a new therapy proven to be effective in the treatment of MRSA.
Scientists in the UK have found that a type of amoeba acts as an incubator for MRSA bacteria. As amoebae are often found in healthcare environments this discovery has implications for the infection control strategies adopted by hospitals.
Antibiotic resistance is a major problem worldwide and there is an urgent need for new antibiotics to be developed. Potential new drugs are usually made in the lab which is complicated and time-consuming.
Cerexa has announced that the U.S. Food and Drug Administration (FDA) has granted Fast Track designation for PPI-0903, a next-generation, broad-spectrum, cephalosporin antibiotic, for the treatment of complicated skin and skin structure infections (cSSSI) caused by methicillin-resistant Staphylococcus aureus (MRSA).
Staph infections resistant to antibiotics, previously only associated with hospitalization or prior contact with the healthcare system, are now widespread in the community and coming home.
The MRSA 'superbug' evades many of the measures introduced to combat its spread by infecting a common single-celled organism found almost everywhere in hospital wards, according to new research published in the journal Environmental Microbiology.
According to the prestigious British Medical Association (BMA), doctors should abandon wearing ties and traditional white coats to work because they could harbour deadly hospital superbugs.
A new screening technique for methicillin-resistant Staphylococcus aureus (MRSA) cuts by 75% the time taken to identify patients carrying MRSA and could be used to help prevent transmission of the bacteria in hospitals.
Copper could help prevent the spread of flu infections. Recent research at the University of Southampton shows that the Influenza A virus is virtually eradicated within six hours on copper surfaces.
As part of the shake up of the National Health Service in Britain the health secretary Patricia Hewitt has named the top worse managers.
According to Canadian researchers bacteria in dirt may be "born" with a resistance to antibiotics, and studying bacteria in the soil may provide key clues to understanding how the superbugs develop resistance to antibiotics.
German researchers have proposed an automated DNA sequence-based early warning system to detect methicillin-resistant Staphylococcus aureus (MRSA) outbreaks in hospitals, which they say could replace traditional slower techniques.
A dangerous drug-resistant bacterium is becoming more prevalent in many intensive care units, according to an article in the Feb. 1 issue of Clinical Infectious Diseases, now available online.
A vibrating disc no bigger than a speck of dust could help to diagnose and monitor common types of cancer and provide specialists with information about the most appropriate therapy.
New research estimates that about 2 million people carry a strain of drug-resistant bacteria in their noses.
According to reports eleven patients at a British hospital have acquired a superbug said to be stronger than MRSA.
Can it be that the stress on the use of antiseptics and antibiotics in hospitals is actually putting patients at a greater risk of suffering fatal bacterial infection?
Terms
While we only use edited and approved content for Azthena
answers, it may on occasions provide incorrect responses.
Please confirm any data provided with the related suppliers or
authors. We do not provide medical advice, if you search for
medical information you must always consult a medical
professional before acting on any information provided.
Your questions, but not your email details will be shared with
OpenAI and retained for 30 days in accordance with their
privacy principles.
Please do not ask questions that use sensitive or confidential
information.
Read the full Terms & Conditions.